SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jatinderpal Kaur Kalsi, Usha Menon, Current developments in ovarian cancer screening, Expert Review of Obstetrics & Gynecology, 2012, 7, 2, 131

    CrossRef

  2. 2
    Barbara A. Goff, Ovarian Cancer, Obstetrics and Gynecology Clinics of North America, 2012, 39, 2, 183

    CrossRef

  3. 3
    Meir Jonathon Solnik, Carolyn Alexander, Ovarian incidentaloma, Best Practice & Research Clinical Endocrinology & Metabolism, 2012, 26, 1, 105

    CrossRef

  4. 4
    Aleksandra Gentry-Maharaj, Usha Menon, Screening for ovarian cancer in the general population, Best Practice & Research Clinical Obstetrics & Gynaecology, 2012, 26, 2, 243

    CrossRef

  5. 5
    Danielle Vicus, William Small, Allan Covens, Clinical Radiation Oncology, 2012,

    CrossRef

  6. 6
    Jeffrey D. Seidman, Po Zhao, Anna Yemelyanova, “Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer, Gynecologic Oncology, 2011, 120, 3, 470

    CrossRef

  7. 7
    J.N. McAlpine, S. El Hallani, S.F. Lam, S.E. Kalloger, M. Luk, D.G. Huntsman, C. MacAulay, C.B. Gilks, D.M. Miller, P.M. Lane, Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: A promising step towards screening and early detection, Gynecologic Oncology, 2011, 120, 3, 385

    CrossRef

  8. 8
    Sándor Valent, Orsolya Oláh, Levente Sára, Attila Pajor, Zoltán Langmár, Az ultrahangvizsgálat szerepe a méhtest és a petefészek rosszindulatú daganatainak diagnosztikájában, Orvosi Hetilap, 2011, 152, 47, 1887

    CrossRef

  9. 9
    Sophie Taïeb, Philippe Vennin, Dépistage du cancer de l’ovaire : le point en 2011, Imagerie de la Femme, 2011, 21, 2, 45

    CrossRef

  10. 10
    Mahesh K. Shetty, Adhemar Longatto-Filho, Early Detection of Breast, Cervical, Ovarian and Endometrial Cancers in Low Resource Countries: An Integrated Approach, Indian Journal of Surgical Oncology, 2011, 2, 3, 165

    CrossRef

  11. 11
    Karolina Partheen, Björg Kristjansdottir, Karin Sundfeldt, Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass, Journal of Gynecologic Oncology, 2011, 22, 4, 244

    CrossRef

  12. 12
    ShuQi. Wang, Xiaohu Zhao, Imran Khimji, Ragip Akbas, Weiliang Qiu, Dale Edwards, Daniel W. Cramer, Bin Ye, Utkan Demirci, Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care, Lab on a Chip, 2011, 11, 20, 3411

    CrossRef

  13. 13
    John Rensselaer van Nagell, Rachel Ware Miller, Christopher P. DeSimone, Frederick R. Ueland, Iwona Podzielinski, Scott T. Goodrich, Jeff W. Elder, Bin Huang, Richard J. Kryscio, Edward John Pavlik, Long-Term Survival of Women With Epithelial Ovarian Cancer Detected by Ultrasonographic Screening, Obstetrics & Gynecology, 2011, 118, 6, 1212

    CrossRef

  14. 14
    James H. Liu, Kristine M. Zanotti, Management of the Adnexal Mass, Obstetrics & Gynecology, 2011, 117, 6, 1413

    CrossRef

  15. 15
    Annekathryn Goodman, Measuring success in ovarian cancer risk reducing strategies, Cancer, 2011, 117, 12
  16. 16
    Maria Koutsaki, Apostolos Zaravinos, Demetrios A. Spandidos, Modern Trends into the Epidemiology and Screening of Ovarian Cancer. Genetic Substrate of the Sporadic Form, Pathology & Oncology Research, 2011, 18, 2, 135

    CrossRef

  17. 17
    Sarah J. Nyante, Amanda Black, Aimée R. Kreimer, Máire A. Duggan, J. Daniel Carreon, Bruce Kessel, Saundra S. Buys, Lawrence R. Ragard, Karen A. Johnson, Barbara K. Dunn, Lois Lamerato, John M. Commins, Christine D. Berg, Mark E. Sherman, Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial, Gynecologic Oncology, 2011, 120, 3, 474

    CrossRef

  18. 18
    Brandon J. D. Rein, Sajal Gupta, Rima Dada, Joelle Safi, Chad Michener, Ashok Agarwal, Potential Markers for Detection and Monitoring of Ovarian Cancer, Journal of Oncology, 2011, 2011, 1

    CrossRef

  19. You have free access to this content19
    M. J. Titulaer, R. Soffietti, J. Dalmau, N. E. Gilhus, B. Giometto, F. Graus, W. Grisold, J. Honnorat, P. A. E. Sillevis Smitt, R. Tanasescu, C. A. Vedeler, R. Voltz, J. J. G. M. Verschuuren, Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force, European Journal of Neurology, 2011, 18, 1
  20. 20
    Miriam Lenhard, Petra Stieber, Linda Hertlein, Angela Kirschenhofer, Sophie Fürst, Doris Mayr, Dorothea Nagel, Karin Hofmann, Katja Krocker, Alexander Burges, The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses, Clinical Chemistry and Laboratory Medicine, 2011, 49, 12, 2081

    CrossRef

  21. 21
    Archana Rao, Jonathan Carter, Ultrasound and Ovarian Cancer Screening: Is There a Future?, Journal of Minimally Invasive Gynecology, 2011, 18, 1, 24

    CrossRef

  22. 22
    Toshiyuki Hata, Kohkichi Hata, Junko Noguchi, Kenji Kanenishi, Atsuko Shiota, Ultrasound for evaluation of adnexal malignancy: From 2D to 3D ultrasound, Journal of Obstetrics and Gynaecology Research, 2011, 37, 10
  23. 23
    Tara Henrichsen, Douglas L. Brown, Gynecologic Imaging, 2011,

    CrossRef

  24. 24
    Ann K. Folkins, Elke A. Jarboe, Jonathan L. Hecht, Michael G. Muto, Christopher P. Crum, Diagnostic Gynecologic and Obstetric Pathology, 2011,

    CrossRef

  25. 25
    Douglas L. Brown, Rochelle F. Andreotti, Susanna I. Lee, Sandra O. DeJesus Allison, Genevieve L. Bennett, Theodore Dubinsky, Phyllis Glanc, Mindy M. Horrow, Anna S. Lev-Toaff, Neil S. Horowitz, Ann E. Podrasky, Leslie M. Scoutt, Carolyn M. Zelop, ACR Appropriateness Criteria© Ovarian Cancer Screening, Ultrasound Quarterly, 2010, 26, 4, 219

    CrossRef

  26. 26
    Marta E. Heilbrun, Jeffery Olpin, Akram Shaaban, Imaging of Benign Adnexal Masses, Topics in Magnetic Resonance Imaging, 2010, 21, 4, 213

    CrossRef

  27. 27
    Akram Shaaban, Maryam Rezvani, Ovarian Cancer, Topics in Magnetic Resonance Imaging, 2010, 21, 4, 247

    CrossRef

  28. 28
    K Stephen Suh, Sang W Park, Angelica Castro, Hiren Patel, Patrick Blake, Michael Liang, Andre Goy, Ovarian cancer biomarkers for molecular biosensors and translational medicine, Expert Review of Molecular Diagnostics, 2010, 10, 8, 1069

    CrossRef

  29. 29
    Alison M. Karst, Ronny Drapkin, Ovarian Cancer Pathogenesis: A Model in Evolution, Journal of Oncology, 2010, 2010, 1

    CrossRef

  30. 30
    John M. McDonald, Stacey Doran, Christopher P. DeSimone, Fred R. Ueland, Paul D. DePriest, Rachel A. Ware, Brook A. Saunders, Edward J. Pavlik, Scott Goodrich, Richard J. Kryscio, John R. van Nagell, Predicting Risk of Malignancy in Adnexal Masses, Obstetrics & Gynecology, 2010, 115, 4, 687

    CrossRef

  31. 31
    Robert T. Greenlee, Bruce Kessel, Craig R. Williams, Thomas L. Riley, Lawrence R. Ragard, Patricia Hartge, Saundra S. Buys, Edward E. Partridge, Douglas J. Reding, Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial, American Journal of Obstetrics and Gynecology, 2010, 202, 4, 373.e1

    CrossRef

  32. 32
    Brook A. Saunders, Iwona Podzielinski, Rachel A. Ware, Scott Goodrich, Christopher P. DeSimone, Fred R. Ueland, Leigh Seamon, Jessalyn Ubellacker, Edward J. Pavlik, Richard J. Kryscio, John R. van Nagell, Risk of malignancy in sonographically confirmed septated cystic ovarian tumors, Gynecologic Oncology, 2010, 118, 3, 278

    CrossRef

  33. 33
    Brian Nolen, Liudmila Velikokhatnaya, Adele Marrangoni, Koen De Geest, Aleksey Lomakin, Robert C. Bast, Anna Lokshin, Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass, Gynecologic Oncology, 2010, 117, 3, 440

    CrossRef

  34. 34
    John O. Schorge, Susan C. Modesitt, Robert L. Coleman, David E. Cohn, Noah D. Kauff, Linda R. Duska, Thomas J. Herzog, SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance, Gynecologic Oncology, 2010, 119, 1, 7

    CrossRef

  35. 35
    Galina Lurie, Lynne R. Wilkens, Pamela J. Thompson, Rayna K. Matsuno, Michael E. Carney, Marc T. Goodman, Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: A case analysis, Gynecologic Oncology, 2010, 119, 2, 278

    CrossRef

  36. 36
    N B Rettenmaier, C R Rettenmaier, T Wojciechowski, L N Abaid, J V Brown, J P Micha, B H Goldstein, The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review, British Journal of Cancer, 2010, 103, 11, 1657

    CrossRef

  37. 37
    MARTA E. HEILBRUN, JEFFERY OLPIN, AKRAM SHAABAN, Imaging of Benign Adnexal Masses: Characteristic Presentations on Ultrasound, Computed Tomography, and Magnetic Resonance Imaging, Clinical Obstetrics and Gynecology, 2009, 52, 1, 21

    CrossRef

  38. 38
    Andrea B Joyner, Carolyn D Runowicz, Ovarian cancer screening and early detection, Women's Health, 2009, 5, 6, 693

    CrossRef

  39. 39
    AKRAM SHAABAN, MARYAM REZVANI, Ovarian Cancer: Detection and Radiologic Staging, Clinical Obstetrics and Gynecology, 2009, 52, 1, 73

    CrossRef

  40. 40
    Miriam S. Lenhard, Stefanie Nehring, Dorothea Nagel, Doris Mayr, Angela Kirschenhofer, Linda Hertlein, Klaus Friese, Petra Stieber, Alexander Burges, Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors, Clinical Chemistry and Laboratory Medicine, 2009, 47, 5, 537

    CrossRef

  41. 41
    Daniel L. Clarke-Pearson, Screening for Ovarian Cancer, New England Journal of Medicine, 2009, 361, 2, 170

    CrossRef

  42. 42
    Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes, Keith Godfrey, David Oram, Jonathan Herod, Karin Williamson, Mourad W Seif, Ian Scott, Tim Mould, Robert Woolas, John Murdoch, Stephen Dobbs, Nazar N Amso, Simon Leeson, Derek Cruickshank, Alistair Mcguire, Stuart Campbell, Lesley Fallowfield, Naveena Singh, Anne Dawnay, Steven J Skates, Mahesh Parmar, Ian Jacobs, Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), The Lancet Oncology, 2009, 10, 4, 327

    CrossRef

  43. 43
    Edward J. Pavlik, Brook A. Saunders, Stacey Doran, Katherine W. McHugh, Frederick R. Ueland, Christopher P. DeSimone, Paul D. DePriest, Rachel A. Ware, Richard J. Kryscio, John R. van Nagell, The search for meaning—Symptoms and transvaginal sonography screening for ovarian cancer, Cancer, 2009, 115, 16
  44. 44
    Ilana Cass, The search for meaning—Symptoms and transvaginal sonography screening for ovarian cancer, Cancer, 2009, 115, 16
  45. 45
    Janice S. Kwon, Charlotte C. Sun, Susan K. Peterson, Kristin G. White, Molly S. Daniels, Stephanie G. Boyd-Rogers, Karen H. Lu, Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome, Cancer, 2008, 113, 2
  46. 46
    Partha M Das, Robert C Bast Jr, Early detection of ovarian cancer, Biomarkers in Medicine, 2008, 2, 3, 291

    CrossRef

  47. 47
    Nishan Chobanian, Charles S. Dietrich, Ovarian Cancer, Surgical Clinics of North America, 2008, 88, 2, 285

    CrossRef

  48. 48
    M. Ascencio, P. Collinet, M. Cosson, S. Mordon, Place et intérêt de la tomographie par cohérence optique en gynécologie, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2007, 36, 8, 749

    CrossRef

  49. 49
    Rebecca Byler Dann, Joseph L. Kelley, Kristin K. Zorn, Strategies for Ovarian Cancer Prevention, Obstetrics and Gynecology Clinics of North America, 2007, 34, 4, 667

    CrossRef

  50. 50
    M. J. Titulaer, R. Soffietti, J. Dalmau, N. E. Gilhus, B. Giometto, F. Graus, W. Grisold, J. Honnorat, P. A. E. Sillevis Smitt, R. Tanasescu, C. A. Vedeler, R. Voltz, J. J. G. M. Verschuuren, Screening for Tumours in Paraneoplastic Syndromes,